Cargando…
Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although their effects when used for STEMI are less cl...
Autores principales: | Moon, Su-Jin, Yoon, Hee-Jeoung, Her, Sung-Ho, Lee, Jong-Min, An, Ho-Jung, Lee, Yune-Jeong, Jin, Seung-Won |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686964/ https://www.ncbi.nlm.nih.gov/pubmed/18787370 http://dx.doi.org/10.3904/kjim.2008.23.3.156 |
Ejemplares similares
-
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
por: Vergara-Jimenez, Jennifer, et al.
Publicado: (2010) -
Spontaneous Bleeding from Internal Pudendal Artery associated with Abciximab after Primary Percutaneous Coronary Intervention: Successful Treatment with Percutaneous Gel-Foam Embolization
por: Lee, Seung-Eun, et al.
Publicado: (2016) -
Alveolar Hemorrhage during Abciximab Infusion
por: Koza, Yavuzer, et al.
Publicado: (2021) -
Cardiac tamponade caused by tuberculosis pericarditis in renal transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2011) -
Fibrinous and hemorrhagic pericarditis with cardiac tamponade due to acute myeloid leukemia
por: Zanelli, Magda, et al.
Publicado: (2021)